Published in J Gen Microbiol on November 01, 1970
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02
Ethidium bromide inhibits appearance of closed circular viral DNA and integration of virus-specific DNA in duck cells infected by avian sarcoma virus. Nature (1975) 3.63
The synthesis of sendai virus polypeptides in infected cells. Virology (1976) 3.26
Polypeptides specified by the influenza virus genome I. Evidence for eight distinct gene products specified by fowl plague virus. Virology (1976) 3.20
Polypeptides specified by the influenza virus genoma. 2. Assignement of protein coding functions to individual genome segments by in vitro translation. Virology (1977) 2.64
Human papova (wart) virus. Bacteriol Rev (1967) 2.57
Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol (1995) 2.20
Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J Virol (1997) 1.88
Transcription and replication of influenza virus RNA. Virology (1979) 1.77
Characterization of the mRNA of influenza virus. J Virol (1975) 1.71
Nucleotide sequence of fowl plague virus RNA segment 7. J Gen Virol (1982) 1.65
A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells. J Virol (1997) 1.63
Deoxyribonucleic acid-dependent ribonucleic acid polymerase activity in cells infected with influenza virus. J Virol (1968) 1.55
Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect Immun (1984) 1.52
Structure and function of the influenza virus genome. Biochem J (1983) 1.47
Migration of influenza virus-specific polypeptides from cytoplasm to nucleus of infected cells. Virology (1981) 1.44
Reemergence of Ebola virus in Africa. Emerg Infect Dis (1996) 1.40
Inhibition of influenza virus replication by -amanitin: mode of action. Proc Natl Acad Sci U S A (1972) 1.39
Relationship between uridine kinase activity and rate of incorporation of uridine into acid-soluble pool and into RNA during growth cycle of rat hepatoma cells. J Cell Physiol (1969) 1.38
The nucleic acid of Sendai virus and ribonucleic acid synthesis in cells infected by Sendai virus. J Gen Virol (1968) 1.36
The sedimentation of influenza virus and its RNA in sucrose density gradients. J Gen Virol (1968) 1.36
Evidence for the involvement of influenza A (fowl plague Rostock) virus protein P2 in ApG and mRNA primed in vitro RNA synthesis. J Gen Virol (1981) 1.35
Polypeptides specified by the influenza virus genome. 3. Control of synthesis in infected cells. Virology (1979) 1.31
Influenza virus-specific RNA and protein syntheses in cells infected with temperature-sensitive mutants defective in the genome segment encoding nonstructural proteins. J Virol (1980) 1.29
Hantavirus pulmonary syndrome: an emerging infectious disease. Science (1993) 1.28
Mouse cells expressing human intercellular adhesion molecule-1 are susceptible to infection by coxsackievirus A21. J Virol (1997) 1.23
Ribonucleic acid polymerase induced in cells infected with Sendai virus. J Virol (1970) 1.22
Participation of DNA-dependent RNA polymerase II in replication of influenza viruses. Nature (1977) 1.22
Laceration of a mitral papillary muscle and the aortic root as a result of blunt trauma to the chest. Case report and review of the literature. J Thorac Cardiovasc Surg (1984) 1.21
Improved colorimetric assay for detecting influenza B virus neutralizing antibody responses to vaccination and infection. J Clin Microbiol (1989) 1.19
The influenza virus genome and its replication. Br Med Bull (1979) 1.19
Nucleic acid of influenza virus. Nature (1966) 1.18
Genetic recombination between two strains of fowl plague virus: construction of genetic maps. Virology (1979) 1.15
Characterization of the ribonucleic acid of fowl plague virus. Arch Gesamte Virusforsch (1973) 1.15
Lactate dehydrogenase-elevating virus. J Gen Virol (1985) 1.13
Capped mRNAs may stimulate the influenza virion polymerase by allosteric modulation. Virus Res (1984) 1.13
In vitro product of a ribonucleic acid polymerase induced by influenza virus. J Virol (1970) 1.12
RNA-dependent RNA polymerase activity in murine coronavirus-infected cells. J Gen Virol (1983) 1.12
Studies on the mechanism of action of Riley virus. I. Action of substances affecting the reticuloendothelial system on plasma enzyme levels in mice. J Exp Med (1965) 1.11
Strategies of virus persistence. Br Med Bull (1985) 1.10
Characterization of recombinant Eschericha coli 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase: analysis of enzymatic activity and substrate specificity. Biochem Biophys Res Commun (1996) 1.07
Influenza A antigens on human lymphocytes in vitro and probably in vivo. Nature (1976) 1.06
Riley virus neutralizing activity in the plasma of infected mice with persistent viraemia. Virology (1966) 1.05
Method for assigning temperature-sensitive mutations of influenza viruses to individual segments of the genome. Virology (1977) 1.00
Coronary bypass grafting in 376 consecutive patients, with three operative deaths. J Thorac Cardiovasc Surg (1974) 0.99
Multiplication of influenza virus in the presence of cordycepin, an inhibitor of cellular RNA synthesis. Nat New Biol (1973) 0.99
Influence of the host cell on influenza virus replication. Philos Trans R Soc Lond B Biol Sci (1980) 0.98
The development of Akabane virus-induced congenital abnormalities in cattle. Vet Rec (1988) 0.97
An approach to the control of disease transmission in pig-to-human xenotransplantation. Xenotransplantation (2000) 0.95
Studies on the mechanism of action of Riley virus. IV. The reticuloendothelial system and impaired plasma enzyme clearance in infected mice. J Exp Med (1967) 0.94
Integrin alpha v beta 6 enhances coxsackievirus B1 lytic infection of human colon cancer cells. Virology (1997) 0.93
The LDH virus: an interfering biological contaminant. Science (1978) 0.93
Molecular cloning of the nucleoprotein gene of canine distemper virus. J Gen Virol (1984) 0.92
Temperature-sensitive mutants of fowl plague virus: isolation and genetic characterization. Virology (1979) 0.92
Characterization of human parainfluenza viruses. I. The structural proteins of parainfluenza virus 2 and their synthesis in infected cells. J Gen Virol (1983) 0.91
Studies on the mechanism of action of Riley virus. II. Action of substances affecting the reticuloendothelial sysem on the level of viraemia. J Exp Med (1965) 0.89
An impending epidemic of bovine congenital deformities. Aust Vet J (1983) 0.89
Aortocoronary bypass surgery: a 7-year follow-up. Circulation (1979) 0.88
Interaction of influenza A virus with human peripheral blood lymphocytes. Infect Immun (1979) 0.88
The surgical management of an aneurysm of a primitive persistent sciatic artery. Ann Surg (1968) 0.88
Antibody binding to individual short consensus repeats of decay-accelerating factor enhances enterovirus cell attachment and infectivity. J Immunol (1998) 0.88
Hybridization studies of the relationship between influenza virus RNA and cellular DNA. Virology (1976) 0.87
Lactic dehydrogenase virus. Virol Monogr (1975) 0.87
RNA-dependent RNA polymerase in nuclei of cells infected with influenza virus. J Virol (1973) 0.86
A study of respiratory infections in a healthy adult population during the 1987 Australian winter. Fam Pract (1993) 0.86
The surgical management of intracardiac defects due to penetrating trauma. J Thorac Cardiovasc Surg (1973) 0.85
Synthesis of ribonuclease-resistant ribonucleic acid by fowl-plague-virus-induced ribonucleic acid polymerase. Biochem J (1969) 0.85
Experiments in mice and rats on the induction of joint lesions following injections of serum and in chronic virus infection. Int Arch Allergy Appl Immunol (1980) 0.84
Extragenic suppression of a ts phenotype during recombination between ts mutants of two fowl plague virus strains with a ts mutation in gene 1. J Gen Virol (1982) 0.84
Incomplete avian influenza virus contains a defective non-interfering component. Arch Virol (1982) 0.84
RNA polymerase activity in virions of parainfluenza 1 virus (Sendai). Arch Gesamte Virusforsch (1972) 0.84
Combined left ventricular aneurysm and coronary artery bypass surgery: long-term results of 100 consecutive patients. Arch Surg (1978) 0.84
Effects of -amanitin in vivo on RNA polymerase activity of cultured chick embryo fibroblast cell nuclei: resistance of ribosomal RNA synthesis to the drug. FEBS Lett (1973) 0.83
Cytoplasmic interactions between decay-accelerating factor and intercellular adhesion molecule-1 are not required for coxsackievirus A21 cell infection. J Gen Virol (2000) 0.83
Immunization against influenza by the ocular route. Vaccine (1985) 0.82
Experience of a standardised method for assessing respiratory disability. Eur Respir J (1994) 0.82
Detecting the cause of Lyme disease in Australia. Med J Aust (1991) 0.82
Incomplete avian influenza A virus displays anomalous interference. Arch Virol (1982) 0.81
Aortic valve replacement combined with coronary bypass grafts. Long-term results. N Y State J Med (1973) 0.80
Penetrating cardiac trauma. Experience with thirty-four patients in a hospital without cardiopulmonary bypass capability. Am J Surg (1976) 0.80
Identification of the cap-binding protein of two strains of influenza A/FPV. J Gen Virol (1982) 0.79
Detection of an RNA-dependent DNA polymerase activity. Clin Diagn Virol (1996) 0.79
Simultaneous determination of pregnanediol and pregnanolone in urinary extracts by gas chromatography. Clin Chem (1968) 0.79
Coronary bypass grafting in 476 patients consecutively operated on. Chest (1973) 0.79
Choice of saphenous vein segments for aortocoronary grafts. Surgery (1971) 0.78
A study of intranasally administered interferon A (rIFN-alpha 2A) for the seasonal prophylaxis of natural viral infections of the upper respiratory tract in healthy volunteers. Epidemiol Infect (1988) 0.78
Cortical layer III pyramidal dendritic morphology normalizes within 3 weeks after kindling and is dissociated from kindling-induced potentiation. Brain Res (2001) 0.78
The topography of RNA synthesis in cells infected with fowl plague virus. J Gen Virol (1974) 0.78
Western blot analysis of antibody responses to influenza virion proteins. Immunol Cell Biol (1992) 0.78
A simple procedure for the analysis of the structural proteins of influenza and parainfluenza viruses involving adsorption to erythrocytes. J Virol Methods (1984) 0.78
Sex differences in cortical plasticity and behavior following anterior cortical kindling in rats. Cereb Cortex (1999) 0.78
Reverse transcriptase activity and particles of retroviral density in cultured canine lymphosarcoma supernatants. Br J Cancer (1983) 0.78
Synthesis of RNA segments 1-3 during generation of incomplete influenza A (fowl plague) virus. Arch Virol (1982) 0.76
Novel polypeptides encoded by influenza virus subgenomic (DI type) virion RNAs. Virus Res (1985) 0.76